Jerusalem, Israel, June 4, 2010 - Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today announced positive results from a study assessing a new lower-volume injection of Copaxone® (glatiramer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results